🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9486422

Small molecule inhibitors of Mcl-1 and the uses of thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9475822

Substituted 2- amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9468649

Methods of treating epilepsy with transforming growth factor beta inhibitors

The Regents of the University of California · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453028

Protein kinase C inhibitors and uses thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453019

Linked purine pterin HPPK inhibitors useful as antibacterial agents

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9446139

Polymer-based compositions and conjugates of HIV entry inhibitors

Nektar Therapeutics · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9447047

Inhibitors of protein phosphatase-1 and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9428457

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9422271

Pyrimidine compounds as tuberculosis inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9422245

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9422340

Macrocyclic compounds useful as inhibitors of histone deacetylases

The Regents of the University of Colorado, a Body Corporate · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9415105

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9416165

Methods of inhibiting viral replication and improving T cell function employing soluble Ti

The Regents of the University of California · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9408813

Small-molecule inhibitors of dengue virus proteases

The Board of Regents of the University of Texas System · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9408829

Inhibitors of CD40-TRAF6 interaction

Ludwig-Maximilians-Universitat Munchen · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9403856

Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9403819

Apoptosis signal-regulating kinase 1 inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9393245

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9394316

Inhibitors of the plasmodial surface anion channel as antimalarials

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9394303

Small molecule inhibitors of MCL-1 and uses thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9394302

Inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9387205

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

TAKEDA GMBH · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9388408

Oligonucleotide-based inhibitors comprising locked nucleic acid motif

MIRAGEN THERAPEUTICS, INC. · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9388189

Pyrrolotriazinone derivatives as PI3K inhibitors

Almirall, S.A. · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted